103 related articles for article (PubMed ID: 8960390)
21. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides.
Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D
Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins.
McCluskey SA; Whitney RA; Marks GS
Mol Pharmacol; 1989 Oct; 36(4):608-14. PubMed ID: 2811858
[TBL] [Abstract][Full Text] [Related]
23. Elevation of delta-aminolevulinic acid synthase and cytochrome PB1 P450 messenger RNA levels by dihydropyridines, dihydroquinolines, sydnones, and N-ethylprotoporphyrin IX.
Mackie JE; Back DW; Hamilton JW; Marks GS
Biochem Pharmacol; 1991 Jul; 42(3):475-83. PubMed ID: 1859461
[TBL] [Abstract][Full Text] [Related]
24. Chick embryo liver microsomal steroid hydroxylations: induction by dexamethasone, phenobarbital, and glutethimide and inactivation following the in ovo administration of porphyrinogenic compounds.
Kimmett SM; McNamee JP; Marks GS
Can J Physiol Pharmacol; 1996 Jan; 74(1):97-103. PubMed ID: 8963959
[TBL] [Abstract][Full Text] [Related]
25. Comparison of rat and human cytochrome P450 (CYP) sources of N-alkylprotoporphyrin IX. Formation after interaction with porphyrinogenic xenobiotics: studies with cDNA-expressed single CYP enzymes.
Gamble JT; Nakatsu K; Marks GS
Xenobiotica; 2002 Nov; 32(11):997-1006. PubMed ID: 12487729
[TBL] [Abstract][Full Text] [Related]
26. Use of recombinant human ferrochelatase as a sensitive bioassay for N-alkylprotoporphyrin IX formed after interaction of porphyrinogenic xenobiotics with rat liver microsomes.
Gamble JT; Wong SG; Dailey HA; Marks GS
Can J Physiol Pharmacol; 2000 Jul; 78(7):578-81. PubMed ID: 10926165
[TBL] [Abstract][Full Text] [Related]
27. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.
Shen S; Marchick MR; Davis MR; Doss GA; Pohl LR
Chem Res Toxicol; 1999 Feb; 12(2):214-22. PubMed ID: 10027801
[TBL] [Abstract][Full Text] [Related]
28. Effect of enzyme inducers and inhibitors on the pharmacokinetics of oltipraz in rats.
Bae SK; Lee SJ; Kim YH; Kim T; Lee MG
J Pharm Pharmacol; 2005 Apr; 57(4):443-52. PubMed ID: 15831204
[TBL] [Abstract][Full Text] [Related]
29. Evidence for mechanism-based inactivation of rat and chick embryo hepatic cytochrome P4501A and P4503A by dihydropyridines, sydnones, and dihydroquinolines.
Kimmett SM; McNamee JP; Denofreo RT; Marks GS
Biochem Pharmacol; 1994 Jun; 47(11):2069-78. PubMed ID: 8010992
[TBL] [Abstract][Full Text] [Related]
30. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. II.
Kimmett SM; Whitney RA; Marks GS
Mol Pharmacol; 1992 Aug; 42(2):307-10. PubMed ID: 1513328
[TBL] [Abstract][Full Text] [Related]
31. Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes.
Roos PH; Golub-Ciosk B; Kallweit P; Kauczinski D; Hanstein WG
Biochem Pharmacol; 1993 Jun; 45(11):2239-50. PubMed ID: 8517864
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
[TBL] [Abstract][Full Text] [Related]
33. Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic system.
Correia MA; Davoll SH; Wrighton SA; Thomas PE
Arch Biochem Biophys; 1992 Sep; 297(2):228-38. PubMed ID: 1497342
[TBL] [Abstract][Full Text] [Related]
34. Generation of specific antibodies and their use to characterize sex differences in four rat P450 3A enzymes following vehicle and pregnenolone 16alpha-carbonitrile treatment.
Jan YH; Mishin V; Busch CM; Thomas PE
Arch Biochem Biophys; 2006 Feb; 446(2):101-10. PubMed ID: 16448623
[TBL] [Abstract][Full Text] [Related]
35. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
Kasahara M; Suzuki H; Komiya I
Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
[TBL] [Abstract][Full Text] [Related]
36. Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal.
Lunetta JM; Sugiyama K; Correia MA
Mol Pharmacol; 1989 Jan; 35(1):10-7. PubMed ID: 2913483
[TBL] [Abstract][Full Text] [Related]
37. Posttranscriptional elevation of cytochrome P450 3A expression.
Zangar RC; Hernandez M; Novak RF
Biochem Biophys Res Commun; 1997 Feb; 231(1):203-5. PubMed ID: 9070249
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of cytochrome P450 3A1 and P450 3A2 in rat liver following dexamethasone treatment.
Choudhuri S; Zhang XJ; Waskiewicz MJ; Thomas PE
J Biochem Toxicol; 1995 Dec; 10(6):299-307. PubMed ID: 8934632
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the formation of N-alkylprotoporphyrin IX after interaction of porphyrinogenic xenobiotics with single cDNA-expressed human P450 enzymes in microsomes prepared from baculovirus-infected insect cells and human lymphoblastoid cell lines.
Gamble JT; Nakatsu K; Marks GS
Drug Metab Dispos; 2003 Feb; 31(2):202-5. PubMed ID: 12527701
[TBL] [Abstract][Full Text] [Related]
40. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.
Zerilli A; Ratanasavanh D; Lucas D; Goasduff T; Dréano Y; Menard C; Picart D; Berthou F
Chem Res Toxicol; 1997 Oct; 10(10):1205-12. PubMed ID: 9348445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
